Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC ...
Wednesday on the RealClearPolitics podcast, Andrew Walworth, Tom Bevan, and Carl Cannon discussed President Trump introducing ...
Sam Altman has told OpenAI fans to lower their expectations after rumors the company had achieved AGI went viral on X.
Some of the biggest names in technology have clashed after President Donald Trump unveiled his $500 billion private AI investment project.